Wnt/β-catenin signaling in cancers and targeted therapies
Open accessThe DOI matches its Crossref record; 468 of the 468 references it cites were found in a registry or an index.
Abstract
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with the increment of prevalence, advancement of malignant progression, development of poor prognostics, and even ascendence of the cancer-associated mortality. Early experimental investigations have proposed the theoretical potential that efficient repression of this signaling might provide promising therapeutic choices in managing various types of cancers. Up to date, many therapies targeting Wnt/β-catenin signaling in cancers have been developed, which is assumed to endow clinicians with new opportunities of developing more satisfactory and precise remedies for cancer patients with aberrant Wnt/β-catenin signaling. However, current facts indicate that the clinical translations of Wnt/β-catenin signaling-dependent targeted therapies have faced un-neglectable crises and challenges. Therefore, in this study, we systematically reviewed the most updated knowledge of Wnt/β-catenin signaling in cancers and relatively targeted therapies to generate a clearer and more accurate awareness of both the developmental stage and underlying limitations of Wnt/β-catenin-targeted therapies in cancers. Insights of this study will help readers better understand the roles of Wnt/β-catenin signaling in cancers and provide insights to acknowledge the current opportunities and challenges of targeting this signaling in cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inactivation of GSK3β disrupts the integrity and function of the destruction complex, thereby preventing β-catenin phosphorylation. As a result, unphosphorylated, stable β-catenin accumulates in the cytoplasm, translocates to the nucleus, and activates the transcription of its target genes, including c-Myc and Cyclin D1 [35, 46, 47, 52–55].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Xiu, D., Liu, G., Yu, S., Li, L., Zhao, G.-Q., Liu, L., & Li, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1100-8 · Cited by 63 · cited 1×
“With respect to its therapeutic potentials, direct silence of Wnt2 alleviated the xenograft breast cancer growth and rescued the malignance and the chemo-drugs resistance in breast cancers.(58,59)”
BackgroundRetractedWu, Y., Tran, T., Dwabe, S., Sarkissyan, M., Kim, J., Nava, M., Clayton, S., Pietras, R. J., Farias‐Eisner, R., & Vadgama, J. V. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4211-y · Cited by 55 · cited 3×
“Furthermore, it has been implied to elevate the epithelium–mesenchyme transit (EMT) of breast cancers through Wnt/β-catenin.(62,63) In terms of therapeutic choices, the downregulation relieved the progression of CRC by reducing cancer cell proliferation and migration.”
BackgroundInfluentialRetractedXiu, D., Liu, G., Yu, S., Li, L., Zhao, G.-Q., Liu, L., & Li, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02121-3 · Cited by 44
RetractedLi, H., Yang, T., Ning, Q., Shang, D., Yao, Y., & Sun, Z. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.03.016 · Cited by 3
RetractedComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568 · cited 1×
“INTRODUCTION As an evolutionarily conserved signaling that governs numerously vital embryonic and somatic processes, such as cell fate determination, organogenesis, tissue homeostasis, and a variety of pathological conditions, Wnt/β-catenin signaling also plays crucial roles in cancers.(1) Aberrant Wnt/β-catenin signa…”
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554 · cited 1×
“Aberrant Wnt/β-catenin signaling has been uncovered to be tightly woven with many aspects of cancers, including the onset, progression, malignant transformation, and so on.(2,3) Evidence-based medicine has further proved that the abnormal activation of this signaling showed nonnegligible effects on cancer-associated m…”
BackgroundWnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037 · cited 6×
“This SMI stabilized Axin to increase β-catenin degradation by suppressing Tnks1/2.(171) It has been investigated that beside from CRC, XAV939 can constrain certain cancers by inhibiting the Wnt/β-catenin signaling.”
BackgroundInfluentialNusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863 · cited 3×
“BRIEF INTRO OF WNT/Β-CATENIN The nomination of Wnt is after wingless in drosophila and int1 in mammalians.(7,8) As the prerequisite of understanding the roles of Wnt/β-catenin in cancer, in this part, we will briefly introduce the signaling transduction.”
BackgroundThe many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598 · cited 4×
“Finally, after receiving the upstream activation signals, β-catenin functions as the ultimate effector.(31,32) Without canonical Wnt ligands, β-catenin binds to cadherin of cytoplasmic sides rather than being transported into the nucleus, further phosphorylated and eliminated by degradation complex.”
BackgroundInfluentialBinding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
Chen, B., Dodge, M. E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,383 · cited 5×
“In this study, the research group then verified the exclusive activity of inhibiting Wnt-related Porc function by using IWPs.299 IWP has three family members, IWP-1, −2, and -L6, all of which oppress Wnt/β-catenin signaling by competing for the active sites of Porc with Wntless.299 IWP-2 and IWP-L6 had poor metabolic…”
BackgroundInfluentialLgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
de Lau, W., Barker, N., Low, T. Y., Koo, B.-K., Li, V. S. W., Teunissen, H., Kujala, P., Haegebarth, A., Peters, P. J., van de Wetering, M., et al. (2011) · Nature · doi:10.1038/nature10337 · Cited by 1,272 · cited 3×
“Specifically, the Rspo-Lgr complex increases Lrp5/6 phosphorylation and inactivates Wnt repressors Rnf43 and Znrf3.(23,25,26) Rnf43 and Znrf3 are E3 ubiquitin ligases that mediate the degradation of Fzds.”
BackgroundTranscriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258 · cited 3×
“Axin1 mutations were detected widely in HCC.(156,157) This mutation could phenocopy various tumors in animal models.”
BackgroundIkeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226 · cited 1×
“Tankyrase1/2 is a poly (ADP-ribose) polymerase (PARP), attaching PAR chains onto substrates by its catalytic action.(172,173) The enzymes bind and then PARylate Axins, utterly, the Axins are ubiquitylated and degraded.”
BackgroundTumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
Koo, B.-K., Spit, M., Jordens, I., Low, T. Y., Stange, D. E., van de Wetering, M., van Es, J. H., Mohammed, S., Heck, A. J. R., Maurice, M. M., et al. (2012) · Nature · doi:10.1038/nature11308 · Cited by 980 · cited 19×
“Znrf3 and Rnf43 were not essential in the intestine but dysregulation of Znrf3/Rnf43 was important for the growth of CRC.(26,27,123) Mutations of Rnf43, resulting in E3 ubiquitin ligases function loss, promoted CRC development and poor prognosis.”
BackgroundInfluentialZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
Hao, H.-X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., et al. (2012) · Nature · doi:10.1038/nature11019 · Cited by 972 · cited 21×
“Znrf3 and Rnf43 were not essential in the intestine but dysregulation of Znrf3/Rnf43 was important for the growth of CRC.(26,27,123) Mutations of Rnf43, resulting in E3 ubiquitin ligases function loss, promoted CRC development and poor prognosis.”
BackgroundInfluentialRecurrent R-spondin fusions in colon cancer
Seshagiri, S., Stawiski, E. W., Durinck, S., Modrusan, Z., Storm, E. E., Conboy, C. B., Chaudhuri, S., Guan, Y., Janakiraman, V., Jaiswal, B. S., et al. (2012) · Nature · doi:10.1038/nature11282 · Cited by 960 · cited 1×
“In detail, Rspo fusions are regarded as important for tumorigenesis in CRC, by activating Wnt/β-catenin signaling.(119) Rspo2/3 chromosome rearrangements”
BackgroundSatoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960 · cited 3×
“Axin1 mutations were detected widely in HCC.(156,157) This mutation could phenocopy various tumors in animal models.”
BackgroundWnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation
Bilić, J., Huang, Y.-L., Davidson, G., Zimmermann, T., Cruciat, C.-M., Bienz, M., & Niehrs, C. (2007) · Science · doi:10.1126/science.1137065 · Cited by 934
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987) · Cell · doi:10.1016/0092-8674(87)90038-9 · Cited by 931 · cited 3×
“BRIEF INTRO OF WNT/Β-CATENIN The nomination of Wnt is after wingless in drosophila and int1 in mammalians.(7,8) As the prerequisite of understanding the roles of Wnt/β-catenin in cancer, in this part, we will briefly introduce the signaling transduction.”
BackgroundStructural Basis of Wnt Recognition by Frizzled
Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C., & Garcia, K. C. (2012) · Science · doi:10.1126/science.1222879 · Cited by 875 · cited 3×
“Especially, the acylation is necessary for extracellular transport and receptor/co-receptors recognition and bounding.(14,15) With respect to the receptor/co-receptors of Wnt/β-catenin signaling, including frizzled (Fzd) receptors and Lrp”
BackgroundCarmon, K. S., Gong, X., Lin, Q., Thomas, A., & Liu, Q. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106083108 · Cited by 855
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation
Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849
The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals
Piccolo, S., Agius, E., Leyns, L., Bhattacharyya, S., Grunz, H., Bouwmeester, T., & Robertis, E. M. D. (1999) · Nature · doi:10.1038/17820 · Cited by 832
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831 · cited 7×
“Another study showed the incredible use of LGK974 in Rnf43 nonsense mutation cell lines in pancreatic ductal adenocarcinoma (PDAC).124 Both of the two clinical studies illustrated a delayed effect of proliferation inhibition by LGK974.”
BackgroundInfluentialSelf-citationComparing antibody and small-molecule therapies for cancer
Imai, K., & Takaoka, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1913 · Cited by 792 · cited 2×
“Therefore, in in vivo experiments with a complete immune system, mAbs may show better antitumor effects than in in vitro experiments.(274) In addition, mAbs can serve as the vehicle to achieve precision medicine, such as targeting radiogen to tumors.”
BackgroundMonounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt Secretion
Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., & Takada, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.003 · Cited by 788
SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771
Dishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755 · cited 6×
“Moreover, DIX mediated the polymerization of Dvl monomer, which assembles as the anchoring site for Axin and Gsk3β.(197) This process may have significant effects on the ligand–receptor/co-receptor internalization.”
BackgroundInfluentialMutations in AXIN2 Cause Familial Tooth Agenesis and Predispose to Colorectal Cancer
Lammi, L., Arte, S., Somer, M., Järvinen, H., Lahermo, P., Thesleff, I., Pirinen, S., & Nieminen, P. (2004) · The American Journal of Human Genetics · doi:10.1086/386293 · Cited by 691
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Firestein, R., Bass, A. J., Kim, S. Y., Dunn, I. F., Silver, S. J., Guney, I., Freed, E., Ligon, A. H., Vena, N., Ogino, S., et al. (2008) · Nature · doi:10.1038/nature07179 · Cited by 672 · cited 2×
“Thus, CDK8 may be a promising target for β-catenin-associated cancers.(246) The translationally controlled tumor protein (TCTP) can enhance the transcription complex activity by increasing the ability of β-catenin–Tcf binding and then inducing the growth of glioma tumor.”
BackgroundWnt Signaling Pathway in Non-Small Cell Lung Cancer
Stewart, D. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt356 · Cited by 651
Primary Cilia and Mammalian Hedgehog Signaling
Bangs, F., & Anderson, K. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028175 · Cited by 642 · cited 1×
“Wnt/β-catenin and Sonic hedgehog (Shh) signaling The Sonic hedgehog signaling is another important interactor of β-catenin-dependent Wnt signaling.(9,264) Smo, a receptor of Shh ligands,(265) once being triggered via Shh, can activate Gli activities.”
BackgroundGurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614 · cited 1×
“They are characterized by high affinity and low off-target accidents but have longer plasma half-life and lessened clearance rate.(305)”
BackgroundFrizzled and LRP5/6 Receptors for Wnt/ -Catenin Signaling
MacDonald, B. T., & He, X. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007880 · Cited by 612 · cited 2×
“In addition, as co-receptors to Wnt ligands, Lrps consist of Lrp5 and 6, whose extracellular domains interact with Fzds and then its intracellular domains trigger further signaling transduction.(18,19) In addition to receptor/coreceptors, there also exist certain extracellular regulators that can influence the ligand–…”
BackgroundHecht, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1839 · Cited by 607
The casein kinase 1 family: participation in multiple cellular processes in eukaryotes
Knippschild, U., Gocht, A., Wolff, S., Huber, N., Löhler, J., & Stöter, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.011 · Cited by 601 · cited 1×
“They are ubiquitously expressed in human tissues all through the developmental and adult period, and the Wnt/β-catenin signaling pathway is just one of the pathways that CK1s impact.(189) The mechanisms of CK1 isoforms on regulating Wnt/β-catenin pathway are complicated.”
BackgroundCasein kinase 1 γ couples Wnt receptor activation to cytoplasmic signal transduction
Davidson, G., Wu, W., Shen, J., Bilic, J., Fenger, U., Stannek, P., Glinka, A., & Niehrs, C. (2005) · Nature · doi:10.1038/nature04170 · Cited by 581
LGR4 and LGR5 are R‐spondin receptors mediating Wnt/β‐catenin and Wnt/PCP signalling
Glinka, A., Dolde, C., Kirsch, N., Huang, Y., Kazanskaya, O., Ingelfinger, D., Boutros, M., Cruciat, C., & Niehrs, C. (2011) · EMBO reports · doi:10.1038/embor.2011.175 · Cited by 562
Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone, M., Züllig, S., & Basler, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00679-7 · Cited by 561
Daniels, D. L., & Weis, W. I. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb912 · Cited by 551
Wong, H.-C., Bourdelas, A., Krauss, A., Lee, H.-J., Shao, Y., Wu, D., Mlodzik, M., Shi, D.-L., & Zheng, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00427-1 · Cited by 533 · cited 1×
“Dsh, a cytoplasmic protein with three highly conserved sections,(28) directly interacts with the C-terminal of Fzds via its PDZ region.(29,30) Finally, after receiving the upstream activation signals, β-catenin functions as the ultimate effector.”
BackgroundInteraction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 517
Liu, W., Dong, X., Mai, M., Seelan, R. S., Taniguchi, K., Krishnadath, K. K., Halling, K. C., Cunningham, J. M., Qian, C., Christensen, E., et al. (2000) · Nature Genetics · doi:10.1038/79859 · Cited by 510
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485 · cited 7×
“Earlier experiments have shown that pyrvinium inhibited the proliferation of HCT116 and SW480 cell lines by selectively activating CK1α and inhibiting canonical Wnt signaling.(194) This activation may be achieved by allosteric regulation, thereby improving the catalytic ability of CK1 without affecting the binding of…”
BackgroundInfluentialThe Transcriptional Coactivator Cbp Interacts with β-Catenin to Activate Gene Expression
Takemaru, K.-I., & Moon, R. T. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.249 · Cited by 473
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466 · cited 2×
“The most common mutations of Znrf3/Rnf43 were missense and truncating mutations, respectively.(121) Znrf3 mutations were frequently detected in adrenocortical carcinoma, uterine corpus endometrial carcinoma, and skin cutaneous melanoma.”
BackgroundThe APC gene in colorectal cancer
Fodde, R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00040-0 · Cited by 461 · cited 1×
“And mutations of Apc directly or indirectly lead to tumorigenesis as well.(132) Mechanistically, Apc regulates β-catenin phosphorylation and restrains the nuclear trans-localization of β-catenin(95,133) (Fig.”
BackgroundCrystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation
Barker, N. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4935 · Cited by 452
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Zhang, L., & Shay, J. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw332 · Cited by 449 · cited 13×
“The constitutive activation form of β-catenin, the exon 3 mutations, is believed to regulate the Signal Transduction and Targeted Therapy (2021) 6:307 genesis of hereditary non-polyposis CRC.208 In CRC, there are several mutations of β-catenin, leading to abnormally activated Wnt/β-catenin signaling.209 The mutations…”
BackgroundInfluentialNotum deacylates Wnt proteins to suppress signalling activity
Kakugawa, S., Langton, P. F., Zebisch, M., Howell, S. A., Chang, T.-H., Liu, Y., Feizi, T., Bineva, G., O’Reilly, N., Snijders, A. P., et al. (2015) · Nature · doi:10.1038/nature14259 · Cited by 446
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., Mysorekar, I. U., & Beachy, P. A. (2011) · Nature · doi:10.1038/nature09851 · Cited by 443 · cited 1×
“Intriguingly, Gsk3β and CK1α can both phosphorylate and active Glis to reciprocally enhance Wnt/β-catenin signaling activity.(267,268) The crosstalk of Shh-Wnt/β-catenin involves the relapse, invasion, and metastasis of certain cancers, so that the repression of this crosstalk may alleviate the progression, migration,…”
BackgroundThe DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization
Schwarz-Romond, T., Fiedler, M., Shibata, N., Butler, P. J. G., Kikuchi, A., Higuchi, Y., & Bienz, M. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1247 · Cited by 435 · cited 1×
“Dsh, a cytoplasmic protein with three highly conserved sections,(28) directly interacts with the C-terminal of Fzds via its PDZ region.(29,30) Finally, after receiving the upstream activation signals, β-catenin functions as the ultimate effector.”
BackgroundRNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling
Zhang, Y., Liu, S., Mickanin, C., Feng, Y., Charlat, O., Michaud, G. A., Schirle, M., Shi, X., Hild, M., Bauer, A., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2222 · Cited by 431 · cited 1×
“The enzymes bind and then PARylate Axins, utterly, the Axins are ubiquitylated and degraded.(174,175) Additionally, researches showed that tankyrase enhanced Wnt/β-catenin signaling.”
BackgroundAPC gene: database of germline and somatic mutations in human tumors and cell lines
Beroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.121 · Cited by 420 · cited 14×
“More than 1500 mutations of Apc were detected over multiple tumors, and majorly in CRC.(127) Meanwhile, the most mutant sites were located on exon 15.”
BackgroundInfluentialInactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma
Jiang, X., Hao, H.-X., Growney, J. D., Woolfenden, S., Bottiglio, C., Ng, N., Lu, B., Hsieh, M. H., Bagdasarian, L., Meyer, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307218110 · Cited by 414 · cited 3×
“The LoF mutation of Znrf3/Rnf43 was reported to be oncogenic, and Porc inhibitors had shown a remarkable potency in this aspect.(27,124,278) Unfortunately, the absence of Apc is likely to induce a Wnt ligand-independent signaling, so tumors with Apc LoF mutations may be resistant to Porc inhibitors.”
BackgroundResultCrystal Structure of a β-Catenin/Tcf Complex
Graham, T. A., Weaver, C., Mao, F., Kimelman, D., & Xu, W. (2000) · Cell · doi:10.1016/s0092-8674(00)00192-6 · Cited by 405
Kishida, S., Yamamoto, H., Hino, S.-I., Ikeda, S., Kishida, M., & Kikuchi, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4414 · Cited by 400 · cited 4×
“DIX, a highly conserved domain, is indispensable for the recognition of Axin.196 Moreover, DIX mediated the polymerization of Dvl monomer, which assembles as the anchoring site for Axin and Gsk3β.197 This process may have significant effects on the ligand–receptor/co-receptor internalization.”
BackgroundInfluentialPP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism
Ueki, Y., Tiziani, V., Santanna, C., Fukai, N., Maulik, C., Garfinkle, J., Ninomiya, C., doAmaral, C., Peters, H., Habal, M., et al. (2001) · Nature Genetics · doi:10.1038/88832 · Cited by 385 · cited 1×
“In the human genome, the gain of function (GoF) of SH3BP2 promoted osteoclastogenesis so which led to bone loss.(327) Although SH3BP2 can also promote the differentiation and maturation of osteoblasts,(328) Tnks inhibitors dominantly showed an osteoclastogenesis effect in vivo, because the concentration needed for sti…”
BackgroundProffitt, K. D., Madan, B., Ke, Z., Pendharkar, V., Ding, L., Lee, M. A., Hannoush, R. N., & Virshup, D. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2258 · Cited by 382
Beta-catenin mutations in human prostate cancer.
Voeller, H. J., Truica, C., & Gelmann, E. P. (1998) · PubMed · Cited by 371
Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR)
Huang, S., Armstrong, E. A., Benavente, S., Chinnaiyan, P., & Harari, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0562 · Cited by 366
Jaiswal, A. S., Marlow, B. P., Gupta, N., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205947 · Cited by 363
The APC tumour suppressor has a nuclear export function
Rosin-Arbesfeld, R., Townsley, F., & Bienz, M. (2000) · Nature · doi:10.1038/35023016 · Cited by 343 · cited 1×
“In contrast, the abnormal expression or truncation of Apc weakened the ability of tumor inhibition.(135) Studies indicated that R2 and B motifs of Apc were the binding sites of Apc-Gsk3β/Axin, by which complex the diversity and structural stability of Axin were promoted.”
BackgroundWnt addiction of genetically defined cancers reversed by PORCN inhibition
Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V, Ghosh, K., Virshup, I. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 341 · cited 2×
“By the way, ETC131, a similar compound of ETC159, is only used for in vitro assays as a result of its inferior oral bioavailability.(283)”
BackgroundProtein phosphatase 2A: a panoply of enzymes
Virshup, D. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00074-5 · Cited by 330
Waaler, J., Machon, O., Tumova, L., Dinh, H., Korinek, V., Wilson, S. R., Paulsen, J. E., Pedersen, N. M., Eide, T. J., Machonova, O., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3336 · Cited by 328 · cited 1×
“JW55 also worked well in the murine PDX CRC model with Apc mutation.(337) G007-LK is an analog of JW74, and G244-LM is analogous to XAV939.”
BackgroundKurnit, K. C., Kim, G. N., Fellman, B. M., Urbauer, D. L., Mills, G. B., Zhang, W., & Broaddus, R. R. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.15 · Cited by 325 · cited 3×
“Besides, β-catenin mutations may be a significant carcinogenic factor in endometrial carcinoma.(215,216) Apart from the direct regulatory functions on tumorigenesis, the characteristics of β-catenin can also provide an approach to estimate the stage of low-graded, early-staged endometrial cancer recurrence.”
BackgroundSinner, D., Kordich, J. J., Spence, J. R., Opoka, R., Rankin, S., Lin, S.-C. J., Jonatan, D., Zorn, A. M., & Wells, J. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02179-06 · Cited by 321 · cited 2×
“Specifically, HOXB13 expression was downregulated in colorectal and prostate cancer.240,241 And it inhibited the growth of cancers by reducing Tcf and c-myc protein levels.240,241 RUNX3 inhibited Wnt/β-catenin signaling by comprising of a ternary complex with β-catenin–Tcf and attenuates growth and progression of mult…”
BackgroundInduction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
Tao, J., Calvisi, D. F., Ranganathan, S., Cigliano, A., Zhou, L., Singh, S., Jiang, L., Fan, B., Terracciano, L., Armeanu–Ebinger, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.004 · Cited by 317 · cited 1×
“In addition, the transcription complex recruits p300/CBP,(222,223) Bcl9,(224) Pontin522,(225) Reptin52,(225) Brg-1,(226,227) Mllt/Af10-Dot1,(228) SOX10,(229) p68/p72,(230) βTrCp1/Fbw1a,(231) FOXM1, and yes-associated protein 1 (YAP1).(235,236) However, in CRC, HIFα can competitively bound to β-catenin to abolish the T…”
BackgroundA Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation–Driven Colorectal Tumor Growth
Lau, T., Chan, E., Callow, M., Waaler, J., Boggs, J., Blake, R. A., Magnuson, S., Sambrone, A., Schutten, M., Firestein, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4562 · Cited by 316 · cited 1×
“Compound G007-LK and G244-LM can damage the proliferation, colony formation, and growth of CRC cells via activating Axins to suppress Wnt/β-catenin signaling.(338) As an adjuvant, G007-LK can also enhance the sensitivity of glioma stem cells to a chemo drug temozolomide and CRC cells to PI3K/EGFR inhibitors.”
BackgroundA phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Structural basis for recruitment of glycogen synthase kinase 3β to the axin—APC scaffold complex
Dajani, R., Fraser, E., Roe, S. M., Yeo, M., Good, V. M., Thompson, V., Dale, T. C., & Pearl, L. H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg068 · Cited by 315 · cited 1×
“The DIX domain directly affects Dsh protein,(149,151) and AxinCR binds to β-catenin and Gsk3β to regulate Wnt/β-catenin signaling.(33,149,152) Some researches indicated that a single point mutation of Axin destroyed the stabilization of the RGS domain, resulting in Axin polymerization.”
BackgroundMcCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Franklin, R. A., Montalto, G., Cervello, M., Libra, M., Candido, S., Malaponte, G., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.659 · Cited by 314
Ha, N.-C., Tonozuka, T., Stamos, J. L., Choi, H.-J., & Weis, W. I. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.010 · Cited by 304 · cited 5×
“Just as mentioned above, as an antiparasitic agent pyrvinium also inhibited Wnt/β-catenin pathway via activating CK1α, or Gsk3β.194,361 Other old drugs like niclosamide to inhibit canonical Wnt signaling by promoting Fzd1 endocytosis,404 celecoxib to induce the degradation of Tcf7,405 and salinomycin to target LRP6.”
InfluentialSakanaka, C., Weiss, J. B., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3020 · Cited by 302
de Lau, W. B., Snel, B., & Clevers, H. C. (2012) · Genome Biology · doi:10.1186/gb-2012-13-3-242 · Cited by 299
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Unterleuthner, D., Neuhold, P., Schwarz, K., Janker, L., Neuditschko, B., Nivarthi, H., Crncec, I., Kramer, N., Unger, C., Hengstschläger, M., et al. (2020) · Angiogenesis · doi:10.1007/s10456-019-09688-8 · Cited by 299
Pontin52 and Reptin52 function as antagonistic regulators of beta-catenin signalling activity
Bauer, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6121 · Cited by 292
Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
Riffell, J. L., Lord, C. J., & Ashworth, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3868 · Cited by 285
Targeting GSK3 and Associated Signaling Pathways Involved in Cancer
Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Martelli, A. M., Cocco, L., Ratti, S., Candido, S., Libra, M., Montalto, G., et al. (2020) · Cells · doi:10.3390/cells9051110 · Cited by 284
Dishevelled and Wnt signaling: is the nucleus the final frontier?
Habas, R., & Dawid, I. B. (2005) · Journal of Biology · doi:10.1186/jbiol22 · Cited by 280 · cited 1×
“Newish founds also indicated that Dvls shuttled between the membrane and the nucleus, and chances were that two distinct Dvls pools may exist.(198,199) However, these discoveries were vague about the druggability of Dvl.”
BackgroundHedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation process
Rohatgi, R., Milenkovic, L., Corcoran, R. B., & Scott, M. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813373106 · Cited by 280
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0244 · Cited by 278 · cited 1×
“Also, Fzd4 and Fzd5 were reported to be significantly increased in prostate cancer.(92,93) Fzd6 highly emerged in CRC, breast cancer, and bladder cancer.”
BackgroundEvidence for the direct involvement of βTrCP in Gli3 protein processing
Wang, B., & Li, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509927103 · Cited by 273
Osada, T., Chen, M., Yang, X. Y., Spasojevic, I., Vandeusen, J. B., Hsu, D., Clary, B. M., Clay, T. M., Chen, W., Morse, M. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3978 · Cited by 271
β-Catenin Mediates the Establishment and Drug Resistance of MLL Leukemic Stem Cells
Yeung, J., Esposito, M. T., Gandillet, A., Zeisig, B. B., Griessinger, E., Bonnet, D., & So, C. W. E. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 270
Wu, Y., Ginther, C., Kim, J., Mosher, N., Chung, S., Slamon, D., & Vadgama, J. V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0155-t · Cited by 268 · cited 3×
“Furthermore, it has been implied to elevate the epithelium–mesenchyme transit (EMT) of breast cancers through Wnt/β-catenin.(62,63) In terms of therapeutic choices, the downregulation relieved the progression of CRC by reducing cancer cell proliferation and migration.”
BackgroundInfluentialCetuximab: An epidermal growth factor receptor chimeric human-murine monoclonal antibody
Harding, J., & Burtness, B. (2005) · Drugs of Today · doi:10.1358/dot.2005.41.2.882662 · Cited by 261 · cited 1×
“With respect to the direct functions, mAbs bind to receptors or ligands to block signal recognition or mediate internalization to reduce the density of receptors on the cell membrane surface.(271) When acting indirectly, mAbs induce complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADC…”
BackgroundTargeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
Le, P. N., McDermott, J. D., & Jimeno, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.08.005 · Cited by 253 · cited 1×
“OMP54F28, namely ipafricept, is the chimera of truncated Fzd8 and IgG1 Fc region.(306) Ipafricept shares many features with vanticumab.”
BackgroundWnt Proteins in Mammary Development and Cancer
Brennan, K. R., & Brown, A. M. C. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000037157.94207.33 · Cited by 248 · cited 1×
“The extracellular secretion and functions of Wnt ligands depend on post-transcriptional modifications.(10) The post-transcriptional modifications of Wnt ligands mainly include glycosylation, palmitoylation, and acylation.”
BackgroundHolcombe, R. F., Nguyen, A., Martinez, Stamos, M. J., Moyer, M. P., Planutis, K., Hope, & Holcombe, R. F. (2009) · Cancer Management and Research · doi:10.2147/cmar.s4544 · Cited by 248 · cited 1×
“Resveratrol has been enrolled into two phase I clinical trials, investigating its value in the dietary supplement in CRC prophylaxis.(400,401) Moreover, silibinin, an extract from the milk thistle seeds, also showed its potentiality in preventing tumorigenesis in a preclinical model.”
MethodTargeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
Takada, K., Zhu, D., Bird, G. H., Sukhdeo, K., Zhao, J.-J., Mani, M., Lemieux, M., Carrasco, D. E., Ryan, J., Horst, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003808 · Cited by 245 · cited 1×
“SAH-BCL9 showed a significant antitumor effect in both colo320 in vitro and intraperitoneally injected murine model in vivo.(395) Fig.”
BackgroundIGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis
Zhu, W., Shiojima, I., Ito, Y., Li, Z., Ikeda, H., Yoshida, M., Naito, A. T., Nishi, J.-I., Ueno, H., Umezawa, A., et al. (2008) · Nature · doi:10.1038/nature07027 · Cited by 241
Post-translational palmitoylation and glycosylation of Wnt-5a are necessary for its signalling
Kurayoshi, M., Yamamoto, H., Izumi, S., & Kikuchi, A. (2007) · Biochemical Journal · doi:10.1042/bj20061476 · Cited by 241
Shan, B.-E., Wang, M.-X., & Li, R.-Q. (2009) · Cancer Investigation · doi:10.1080/07357900802337191 · Cited by 240
Xing, Y., Clements, W. K., Kimelman, D., & Xu, W. (2003) · Genes & Development · doi:10.1101/gad.1142603 · Cited by 237 · cited 3×
“The DIX domain directly affects Dsh protein,(149,151) and AxinCR binds to β-catenin and Gsk3β to regulate Wnt/β-catenin signaling.(33,149,152) Some researches indicated that a single point mutation of Axin destroyed the stabilization of the RGS domain, resulting in Axin polymerization.”
BackgroundFujii, N., You, L., Xu, Z., Uematsu, K., Shan, J., He, B., Mikami, I., Edmondson, L. R., Neale, G., Zheng, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2726 · Cited by 232 · cited 1×
“Such as FJ9, it was significantly reported to cause apoptosis in melanoma and NSCLC cell lines.(370) 3289-8625, another Dvl inhibitor, suppressed the growth of PC-3 cells.”
BackgroundGli proteins and the control of spinal‐cord patterning
Jacob, J., & Briscoe, J. (2003) · EMBO reports · doi:10.1038/sj.embor.embor896 · Cited by 231 · cited 1×
“Glis, including Gli1-3, are the ultimate effectors of Shh signaling as transcriptional regulators.(266) Intriguingly, Gsk3β and CK1α can both phosphorylate and active Glis to reciprocally enhance Wnt/β-catenin signaling activity.”
BackgroundLu, W., Lin, C., Roberts, M. J., Waud, W. R., Piazza, G. A., & Li, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029290 · Cited by 230
Tauriello, D. V. F., Jordens, I., Kirchner, K., Slootstra, J. W., Kruitwagen, T., Bouwman, B. A. M., Noutsou, M., Rüdiger, S. G. D., Schwamborn, K., Schambony, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114802109 · Cited by 230 · cited 1×
“The C-terminus of Fzds is localized in the cytosol which recruits and binds to Dsh to intracellularly trigger subsequent signal cascades.(81) Fzds and Lrp5/6 are indispensable for Wnt/β-catenin activation, and non-eligibly, Fzds receptors, and Lrp5/6 co-receptors are both oncogenic under certain conditions.”
BackgroundBahrami, A., Khazaei, M., Hasanzadeh, M., ShahidSales, S., Joudi Mashhad, M., Farazestanian, M., Sadeghnia, H. R., Rezayi, M., Maftouh, M., Hassanian, S. M., et al. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25950 · Cited by 230
Nuclear localization is required for Dishevelled function in Wnt/β-catenin signaling
Itoh, K., Brott, B. K., Bae, G.-U., Ratcliffe, M. J., & Sokol, S. Y. (2005) · Journal of Biology · doi:10.1186/jbiol20 · Cited by 221
Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction
Lévy, L., Wei, Y., Labalette, C., Wu, Y., Renard, C.-A., Buendia, M. A., & Neuveut, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3404-3414.2004 · Cited by 220
Glycosylation and palmitoylation of Wnt‐3a are coupled to produce an active form of Wnt‐3a
Komekado, H., Yamamoto, H., Chiba, T., & Kikuchi, A. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01068.x · Cited by 220
RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal Tumorigenesis
Ito, K., Lim, A. C.-B., Salto-Tellez, M., Motoda, L., Osato, M., Chuang, L. S. H., Lee, C. W. L., Voon, D. C.-C., Koo, J. K. W., Wang, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.004 · Cited by 219 · cited 1×
“RUNX3 inhibited Wnt/β-catenin signaling by comprising of a ternary complex with β-catenin–Tcf and attenuates growth and progression of multiple cancers, especially in gastric cancer.(242,243) SOX4 can increase β-catenin–Lef/Tcf transcriptional activity through upregulating Tcf4.”
BackgroundDishevelled: A masterful conductor of complex Wnt signals
Sharma, M., Castro-Piedras, I., Simmons, G. E., & Pruitt, K. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.004 · Cited by 218
Zebisch, M., Xu, Y., Krastev, C., MacDonald, B. T., Chen, M., Gilbert, R. J. C., He, X., & Jones, E. Y. (2013) · Nature Communications · doi:10.1038/ncomms3787 · Cited by 217 · cited 3×
“Specifically, the Rspo-Lgr complex increases Lrp5/6 phosphorylation and inactivates Wnt repressors Rnf43 and Znrf3.(23,25,26) Rnf43 and Znrf3 are E3 ubiquitin ligases that mediate the degradation of Fzds.”
BackgroundNguyen, A. V., Martinez, M. E., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., & Holcombe, R. F. (2009) · PubMed Central · Cited by 216
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Chen, M., Wang, J., Lu, J., Bond, M. C., Ren, X.-R., Lyerly, H. K., Barak, L. S., & Chen, W. (2009) · Biochemistry · doi:10.1021/bi9009677 · Cited by 213
He, B., Reguart, N., You, L., Mazieres, J., Xu, Z., Lee, A. Y., Mikami, I., McCormick, F., & Jablons, D. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208511 · Cited by 212 · cited 1×
“Therapeutically, Blocking Wnt1 has been found to strengthen the apoptosis of colorectal cancer (CRC) cells via the utilization of Wif1, Wnt1-specific siRNAs, and neutralizing antibodies.(40)”
BackgroundStructural basis of the Axin–adenomatous polyposis coli interaction
Spink, K. E., Polakis, P., & Weis, W. I. (2000) · The EMBO Journal · doi:10.1093/emboj/19.10.2270 · Cited by 210 · cited 1×
“Separately, the RGS domain is responsible for interacting with Apc to phosphorylate β-catenin.(150) The DIX domain directly affects Dsh protein,(149,151) and AxinCR binds to β-catenin and Gsk3β to regulate Wnt/β-catenin signaling.”
BackgroundJimeno, A., Gordon, M., Chugh, R., Messersmith, W., Mendelson, D., Dupont, J., Stagg, R., Kapoun, A. M., Xu, L., Uttamsingh, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2157 · Cited by 209 · cited 1×
“As for ipafricept, in a clinical trial in patients with advanced solid tumors, fragility fractures were reported in two participants at 20 mg/kg q3w.(309) Another trial recruited patients inflicted with recurrent ovarian cancer, in which a patient experienced a pelvic fracture at 5 mg/ kg q3w.”
BackgroundThe kinase TNIK is an essential activator of Wnt target genes
Mahmoudi, T., Li, V. S. W., Ng, S. S., Taouatas, N., Vries, R. G. J., Mohammed, S., Heck, A. J., & Clevers, H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.285 · Cited by 209 · cited 2×
“Tnik is an essential component for Wnt/β-catenin signaling to maintain physiological cell homeostasis.(250,251) Tnik can directly interact with β-catenin and Tcf to modulate Wnt/β-catenin signaling(250,251) (Fig.”
BackgroundFoxM1 and Wnt/β-Catenin Signaling in Glioma Stem Cells
Gong, A., & Huang, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0953 · Cited by 208
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Liu, C.-C., Prior, J., Piwnica-Worms, D., & Bu, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911220107 · Cited by 207
Immune evasion of tumor cells using membrane-bound complement regulatory proteins
Gorter, A., & Meri, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01537-6 · Cited by 206 · cited 1×
“When acting indirectly, mAbs induce complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), or complement-dependent cellmediated cytotoxicity (CDCC).(272,273) Therefore, in in vivo experiments with a complete immune system, mAbs may show better antitumor effects than in in vitro exper…”
BackgroundHayward, P., Brennan, K., Sanders, P., Balayo, T., DasGupta, R., Perrimon, N., & Arias, A. M. (2005) · Development · doi:10.1242/dev.01724 · Cited by 204 · cited 2×
“Notch signaling also involves in the wingless development with Wnt/β-catenin signaling.(256,257) Notch can directly inhibit Armadillo/β-catenin to enhance destruction complex activity.”
BackgroundStructural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6
Ahn, V. E., Chu, M. L.-H., Choi, H.-J., Tran, D., Abo, A., & Weis, W. I. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.003 · Cited by 201
Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
Grandy, D., Shan, J., Zhang, X., Rao, S., Akunuru, S., Li, H., Zhang, Y., Alpatov, I., Zhang, X. A., Lang, R. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009647 · Cited by 201 · cited 1×
“3289-8625, another Dvl inhibitor, suppressed the growth of PC-3 cells.(371) Taken together, the druggability of Dvls remains largely unknown.”
BackgroundHuguet, E., McMahon, J. A., McMahon, A. P., Bicknell, R., & Harris, A. L. (1994) · PubMed · Cited by 198
Wnt–Notch signalling crosstalk in development and disease
Collu, G. M., Hidalgo-Sastre, A., & Brennan, K. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1644-x · Cited by 198 · cited 3×
“THE CROSSTALK OF WNT/Β-CATENIN SIGNALING IN CANCERS Wnt/β-catenin and Notch signaling Notch signaling widely interacts with Wnt/β-catenin signaling in cell homeostasis and embryo development.(255) Notch signaling also involves in the wingless development with Wnt/β-catenin signaling.”
BackgroundActivator or inhibitor? GSK-3 as a new drug target
Takahashi-Yanaga, F. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.022 · Cited by 194
Iannello, A., & Ahmad, A. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-6192-2 · Cited by 193 · cited 1×
“When acting indirectly, mAbs induce complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), or complement-dependent cellmediated cytotoxicity (CDCC).(272,273) Therefore, in in vivo experiments with a complete immune system, mAbs may show better antitumor effects than in in vitro exper…”
BackgroundWang, Z., Shu, W., Lu, M. M., & Morrisey, E. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5022-5030.2005 · Cited by 193
Fu, C. A., Shen, M., Huang, B. C. B., Lasaga, J., Payan, D. G., & Luo, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30729 · Cited by 192 · cited 1×
“In summary, HOXB13 and RUNX3 are identified as suppressors of Wnt/β-catenin signaling by obstructing Tcf4 activity to inhibit tumorigenesis and cancer progression.(248,249)”
BackgroundChoi, M. Y., Widhopf, G. F., Ghia, E. M., Kidwell, R. L., Hasan, M. K., Yu, J., Rassenti, L. Z., Chen, L., Chen, Y., Pittman, E., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.018 · Cited by 192 · cited 1×
“ROR1/mAb UC-961 NCT02222688(433) (P1); NCT03088878(434) (P1b/2); NCT02776917(435) (P1b); Choi et al.(436) CLL, small lymphocytic lymphoma, BC, MCL”
The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways
Borggrefe, T., Lauth, M., Zwijsen, A., Huylebroeck, D., Oswald, F., & Giaimo, B. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.020 · Cited by 192 · cited 2×
“In turn, β-catenin–Lef/Tcf can reciprocally activate Notch signaling by inducing the expression of Jagged1 and Dll1, which are the ligands of Notch signaling.(255,259) In addition, β-catenin reduces Notch1 ubiquitination and increases the expression of Hes1 to interfere with Notch signaling transduction.”
BackgroundXing, Y., Clements, W. K., Trong, I. L., Hinds, T. R., Stenkamp, R. E., Kimelman, D., & Xu, W. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.001 · Cited by 192 · cited 5×
“Just as mentioned above, as an antiparasitic agent pyrvinium also inhibited Wnt/β-catenin pathway via activating CK1α, or Gsk3β.194,361 Other old drugs like niclosamide to inhibit canonical Wnt signaling by promoting Fzd1 endocytosis,404 celecoxib to induce the degradation of Tcf7,405 and salinomycin to target LRP6.”
BackgroundInfluentialFang, L., Zhu, Q., Neuenschwander, M., Specker, E., Wulf-Goldenberg, A., Weis, W. I., von Kries, J. P., & Birchmeier, W. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1519 · Cited by 190 · cited 1×
“LF3, a 4-thioureido-benzenesulfonamide derivative, reduced tumor growth and induced differentiation in a CRC xenograft murine model.(383) Moreover, BC2059, an anthraquinone oxime-analog repressing Lef1/Tcf4 activity, was elucidated to induce the apoptosis of HL-60, HEL, and K562 significantly.”
BackgroundRSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6
Szenker-Ravi, E., Altunoglu, U., Leushacke, M., Bosso-Lefèvre, C., Khatoo, M., Thi Tran, H., Naert, T., Noelanders, R., Hajamohideen, A., Beneteau, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0118-y · Cited by 190 · cited 1×
“Interestingly, Rspo2 mutations were unraveled to associate with tetra-amelia syndrome, contributing to the destruction of Rspo2Lgr binding.(118) Current evidence depicted the crucial roles of somatic mutations of Rspos in cancers.”
BackgroundInvolvement of RNA Helicases p68 and p72 in Colon Cancer
Shin, S., Rossow, K. L., Grande, J. P., & Janknecht, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4652 · Cited by 189
Mani, M., Carrasco, D. E., Zhang, Y., Takada, K., Gatt, M. E., Dutta-Simmons, J., Ikeda, H., Diaz-Griffero, F., Pena-Cruz, V., Bertagnolli, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0773 · Cited by 185
Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Haikarainen, T., Krauss, S., & Lehtio, L. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630101525 · Cited by 182 · cited 1×
“Tankyrase1/2 is a poly (ADP-ribose) polymerase (PARP), attaching PAR chains onto substrates by its catalytic action.(172,173) The enzymes bind and then PARylate Axins, utterly, the Axins are ubiquitylated and degraded.”
BackgroundKim, M., Lee, H. C., Tsedensodnom, O., Hartley, R., Lim, Y.-S., Yu, E., Merle, P., & Wands, J. R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.020 · Cited by 179 · cited 4×
“WNT3AFzd7 interaction activates Wnt/β-catenin signaling in human hepatocellular carcinoma cells and promotes tumorigenesis.(98) Fzd7 is vitally essential for the development of gastric cancer and it is the major receptor of Wnt ligands.”
BackgroundInfluentialArqués, O., Chicote, I., Puig, I., Tenbaum, S. P., Argilés, G., Dienstmann, R., Fernández, N., Caratù, G., Matito, J., Silberschmidt, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3081 · Cited by 178 · cited 1×
“And NVP-TNKS656 also inhibited the metastatic and invasive EMT hallmarks of hepatoma carcinoma cells.(347) AZ1366 is a novel inhibitor of Tnks to constrain NSCLC growth.”
BackgroundNotch is required for wingless signaling in the epidermis of Drosophila
Couso, J. (1994) · Cell · doi:10.1016/0092-8674(94)90195-3 · Cited by 178 · cited 2×
“Notch signaling also involves in the wingless development with Wnt/β-catenin signaling.(256,257) Notch can directly inhibit Armadillo/β-catenin to enhance destruction complex activity.”
BackgroundAPC Is Essential for Targeting Phosphorylated β-Catenin to the SCFβ-TrCP Ubiquitin Ligase
Su, Y., Fu, C., Ishikawa, S., Stella, A., Kojima, M., Shitoh, K., Schreiber, E. M., Day, B. W., & Liu, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.023 · Cited by 174
R-Spondin Potentiates Wnt/β-Catenin Signaling through Orphan Receptors LGR4 and LGR5
Ruffner, H., Sprunger, J., Charlat, O., Leighton-Davies, J., Grosshans, B., Salathe, A., Zietzling, S., Beck, V., Therier, M., Isken, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040976 · Cited by 170
TNIK inhibition abrogates colorectal cancer stemness
Masuda, M., Uno, Y., Ohbayashi, N., Ohata, H., Mimata, A., Kukimoto-Niino, M., Moriyama, H., Kashimoto, S., Inoue, T., Goto, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms12586 · Cited by 168
Li, L., Mao, J., Sun, L., Liu, W., & Wu, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111131200 · Cited by 168
Mo, D., Jiang, P., Yang, Y., Mao, X., Tan, X., Tang, X., Wei, D., Li, B., Wang, X., Tang, L., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.007 · Cited by 168
Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine
Gao, X., & Hannoush, R. N. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1392 · Cited by 167 · cited 1×
“EXTRACELLULAR COMPOSITIONS Porcupine (Porc) Porc is a membrane-bound O-acyltransferase (MBOAT), by whose palmitoylation function Wnt ligands can be subsequently secreted and recognized.(36) After being palmitoylated, Wnt ligands will bind to wntless and be transported into cell membrane from Golgi apparatus(37) (Fig.”
BackgroundComplex interplay between -catenin signalling and Notch effectors in intestinal tumorigenesis
Peignon, G., Durand, A., Cacheux, W., Ayrault, O., Terris, B., Laurent‐Puig, P., Shroyer, N. F., SEUNINGEN, I. V., Honjo, T., Perret, C., et al. (2011) · Gut · doi:10.1136/gut.2009.204719 · Cited by 167
Protein phosphatase 1 regulates assembly and function of the β‐catenin degradation complex
Luo, W., Peterson, A. G., Garcia, B. A., Coombs, G. S., Kofahl, B., Heinrich, R., Shabanowitz, J., Hunt, D. F., Yost, H. J., & Virshup, D. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601607 · Cited by 166 · cited 4×
“DIX, a highly conserved domain, is indispensable for the recognition of Axin.196 Moreover, DIX mediated the polymerization of Dvl monomer, which assembles as the anchoring site for Axin and Gsk3β.197 This process may have significant effects on the ligand–receptor/co-receptor internalization.”
BackgroundInfluentialTargeting the β-catenin nuclear transport pathway in cancer
Jamieson, C., Sharma, M., & Henderson, B. R. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.012 · Cited by 166 · cited 1×
“This image was modified from a published research.(372) Wnt/β-catenin signaling in cancers and targeted.”
MethodNovel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
Waaler, J., Machon, O., von Kries, J. P., Wilson, S. R., Lundenes, E., Wedlich, D., Gradl, D., Paulsen, J. E., Machonova, O., Dembinski, J. L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1282 · Cited by 165 · cited 4×
“The nicotinamide domain is ubiquitous in the PARP enzymes, and its specific site inhibitor is XAV939.”
BackgroundInfluentialThe Traf2- and Nck-interacting Kinase as a Putative Effector of Rap2 to Regulate Actin Cytoskeleton
Taira, K., Umikawa, M., Takei, K., Myagmar, B.-E., Shinzato, M., Machida, N., Uezato, H., Nonaka, S., & Kariya, K.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406370200 · Cited by 164 · cited 1×
“In summary, HOXB13 and RUNX3 are identified as suppressors of Wnt/β-catenin signaling by obstructing Tcf4 activity to inhibit tumorigenesis and cancer progression.(248,249)”
BackgroundSui, H., Zhao, J., Zhou, L., Wen, H., Deng, W., Li, C., Ji, Q., Liu, X., Feng, Y., Chai, N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.013 · Cited by 164 · cited 1×
“Accordingly, utilizing Tanshinone IIA can inhibit CRC angiogenesis by means of interrupting HIF-1α/β-catenin/Tcf3/ Lef1 signaling.(238,239) Besides, HOXB13, SOX4, RUNX3, CDK8, TCTP, and Daxx participate in regulating Wnt/β-catenin signaling to target Tcf in numerous cancers.”
MethodJang, G.-B., Hong, I.-S., Kim, R.-J., Lee, S.-Y., Park, S.-J., Lee, E.-S., Park, J. H., Yun, C.-H., Chung, J.-U., Lee, K.-J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2041 · Cited by 163 · cited 2×
“CWP232228 is such an inhibitor, which was reported to induce apoptosis and cell cycle arrest in HCT116 cells,(380) also to show effects on liver and breast CSCs.(381,382) LF3, a 4-thioureido-benzenesulfonamide derivative, reduced tumor growth and induced differentiation in a CRC xenograft murine model.”
BackgroundInhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Arend, R. C., Londoño-Joshi, A. I., Samant, R. S., Li, Y., Conner, M., Hidalgo, B., Alvarez, R. D., Landen, C. N., Straughn, J. M., & Buchsbaum, D. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.005 · Cited by 161
Prasad, C. P., Rath, G., Mathur, S., Bhatnagar, D., & Ralhan, R. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2009.06.012 · Cited by 161
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
Wang, R., Sun, Q., Wang, P., Liu, M., Xiong, S., Luo, J., Huang, H., Du, Q., Geller, D. A., & Cheng, B. (2016) · Oncotarget · doi:10.18632/oncotarget.6805 · Cited by 159
Frizzled7 as an emerging target for cancer therapy
King, T. D., Zhang, W., Suto, M. J., & Li, Y. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.009 · Cited by 159 · cited 14×
“The constitutive activation form of β-catenin, the exon 3 mutations, is believed to regulate the Signal Transduction and Targeted Therapy (2021) 6:307 genesis of hereditary non-polyposis CRC.208 In CRC, there are several mutations of β-catenin, leading to abnormally activated Wnt/β-catenin signaling.209 The mutations…”
BackgroundInfluentialPorcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3 -mutant neoplasia
Koo, B.-K., van Es, J. H., van den Born, M., & Clevers, H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508113112 · Cited by 158 · cited 1×
“It owns good oral tolerance and efficacy in the MMTV-Wnt1 mouse mammary cancer model,(295) the Znrf3/Rnf43 mouse CRC model.(284) And WNT-C59 satisfactorily prevented tumor growth in mice xenografted with SUNE1 or HNE1 (two nasopharyngeal carcinoma cell lines).”
BackgroundPeptides and Peptidomimetics in Medicine, Surgery and Biotechnology
Gentilucci, L., Tolomelli, A., & Squassabia, F. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777935041 · Cited by 153 · cited 1×
“Although this feature reduces the risk of side effects, it contrarily causes difficulties to reach satisfactory concentration.(277)”
BackgroundCasein kinase 1 and Wnt/β-catenin signaling
Cruciat, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.08.003 · Cited by 153 · cited 2×
“As a composition of the degradation complex, CK1α initiates the phosphorylation of β-catenin.(190) In fact, CK1δ/ε are also involved in this process by phosphorylating Apc (which strengthens the affinity of Apc to β-catenin), in collaboration with Gsk3.”
BackgroundDiamond, J. R., Becerra, C., Richards, D., Mita, A., Osborne, C., O’Shaughnessy, J., Zhang, C., Henner, R., Kapoun, A. M., Xu, L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05817-w · Cited by 152 · cited 1×
“At last, a total of 6 patients experienced fragility fractures, leading to the abolishment of this trial.(312) All those fracture events mentioned above were not reported as dose-limited toxicity, because they took place after the 1st 28d-window-phase.”
BackgroundLeow, P., Tian, Q., Ong, Z. Y., Yang, Z., & Ee, P. L. R. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9311-z · Cited by 151
Tiki1 Is Required for Head Formation via Wnt Cleavage-Oxidation and Inactivation
Zhang, X., Abreu, J. G., Yokota, C., MacDonald, B. T., Singh, S., Coburn, K. L. A., Cheong, S.-M., Zhang, M. M., Ye, Q.-Z., Hang, H. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.039 · Cited by 150
Fischer, M. M., Cancilla, B., Yeung, V. P., Cattaruzza, F., Chartier, C., Murriel, C. L., Cain, J., Tam, R., Cheng, C.-Y., Evans, J. W., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700090 · Cited by 150 · cited 1×
“Mechanically, this combined usage of ipafricept/vanticumab and paclitaxel strengthened the mitotic catastrophe.(308) Table 2.”
BackgroundEttenberg, S. A., Charlat, O., Daley, M. P., Liu, S., Vincent, K. J., Stuart, D. D., Schuller, A. G., Yuan, J., Ospina, B., Green, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007428107 · Cited by 150 · cited 1×
“Basing on these facts, LRP6 neutralizing antibodies were demonstrated to repress tumorigenesis.(116) It is of note that contrarily targeting Lrp5/6 may be not eligible for managing metastasis of breast cancer.”
BackgroundPathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis
Singh, I., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00392.x · Cited by 148 · cited 13×
“The constitutive activation form of β-catenin, the exon 3 mutations, is believed to regulate the Signal Transduction and Targeted Therapy (2021) 6:307 genesis of hereditary non-polyposis CRC.208 In CRC, there are several mutations of β-catenin, leading to abnormally activated Wnt/β-catenin signaling.209 The mutations…”
BackgroundInfluentialMaier, T. J., Janssen, A., Schmidt, R., Geißlinger, G., & Grösch, S. (2005) · The FASEB Journal · doi:10.1096/fj.04-3274fje · Cited by 148
Bahrami, A., Amerizadeh, F., ShahidSales, S., Khazaei, M., Ghayour-Mobarhan, M., Sadeghnia, H. R., Maftouh, M., Hassanian, S. M., & Avan, A. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25903 · Cited by 147
R-spondins can potentiate WNT signaling without LGRs
Lebensohn, A. M., & Rohatgi, R. (2018) · eLife · doi:10.7554/elife.33126 · Cited by 145 · cited 2×
“Rspos could as well activate Wnt/β-catenin signaling via interacting with HSPGs independent of Lgrs.(117) Interestingly, Rspo2 mutations were unraveled to associate with tetra-amelia syndrome, contributing to the destruction of Rspo2Lgr binding.”
BackgroundAutocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
Kramer, N., Schmoellerl, J., Unger, C., Nivarthi, H., Rudisch, A., Unterleuthner, D., Scherzer, M., Riedl, A., Artaker, M., Crnčec, I., et al. (2017) · Oncogene · doi:10.1038/onc.2017.144 · Cited by 145
Regulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding
Mariotti, L., Pollock, K., & Guettler, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14038 · Cited by 144
Aghabozorgi, A. S., Bahreyni, A., Soleimani, A., Bahrami, A., Khazaei, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2019) · Biochimie · doi:10.1016/j.biochi.2018.11.003 · Cited by 144 · cited 1×
“Mutations of Apc can cause familial adenomatous polyposis (FAP), which is also the major hereditary carcinogenic factor in CRC progression.(129,130) A study showed that around 72% of Apc mutations were detected spreading throughout the Apc gene in early-onset CRC.”
BackgroundWnt/β-Catenin Signaling in Liver Cancers
Wang, W., Smits, R., Hao, H., & He, C. (2019) · Cancers · doi:10.3390/cancers11070926 · Cited by 143
Wei, W., Chua, M., Grepper, S., & So, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.24810 · Cited by 141
Physiological regulation of β-catenin stability by Tcf3 and CK1 ϵ
Lee, E., Salic, A., & Kirschner, M. W. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200102074 · Cited by 141
Lü, W., Lin, C., King, T. D., Chen, H., Reynolds, R. C., & Li, Y. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.07.009 · Cited by 139
Cilibrasi, C., Riva, G., Romano, G., Cadamuro, M., Bazzoni, R., Butta, V., Paoletta, L., Dalprà, L., Strazzabosco, M., Lavitrano, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169854 · Cited by 136
Wright, K., Wilson, P., Morland, S., Campbell, I., Walsh, M., Hurst, T., Ward, B., Cummings, M., & Chenevix-Trench, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<625::aid-ijc1>3.0.co;2-2 · Cited by 133 · cited 3×
“Besides, β-catenin mutations may be a significant carcinogenic factor in endometrial carcinoma.(215,216) Apart from the direct regulatory functions on tumorigenesis, the characteristics of β-catenin can also provide an approach to estimate the stage of low-graded, early-staged endometrial cancer recurrence.”
BackgroundFrizzled-7 as a Potential Therapeutic Target in Colorectal Cancer
Ueno, K., Hiura, M., Suehiro, Y., Hazama, S., Hirata, H., Oka, M., Imai, K., Dahiya, R., & Hinoda, Y. (2008) · Neoplasia · doi:10.1593/neo.08320 · Cited by 131 · cited 2×
“92,106–108 Fzd5 functions in prostate and gastric cancer,93,94 and Fzd6 in colorectal, breast, and bladder cancer.94–96 Fzd7 overexpression is detected in numerous cancers, like hepatocellular, breast, and CRC.97 WNT3AFzd7 interaction activates Wnt/β-catenin signaling in human hepatocellular carcinoma cells and promot…”
BackgroundGSK-3β controls NF-kappaB activity via IKKγ/NEMO
Medunjanin, S., Schleithoff, L.-M., Fiegehenn, C., Weinert, S., Zuschratter, W., & Braun-Dullaeus, R. C. (2016) · Scientific Reports · doi:10.1038/srep38553 · Cited by 130
Deka, J., Wiedemann, N., Anderle, P., Murphy-Seiler, F., Bultinck, J., Eyckerman, S., Stehle, J.-C., André, S., Vilain, N., Zilian, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0148 · Cited by 130 · cited 2×
“And after knocking out Bcl9 and B9l in mice, no obvious harmful phenotypes were found, indicating that these genes are of little importance for mammals to balance Wnt signaling in normal tissues.(394) Based on this, Takada et al.”
BackgroundAPC gene: database of germline and somatic mutations in human tumors and cell lines
Laurent-Puig, P. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.269 · Cited by 130
Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas
Nagayama, S., Fukukawa, C., Katagiri, T., Okamoto, T., Aoyama, T., Oyaizu, N., Imamura, M., Toguchida, J., & Nakamura, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208780 · Cited by 129 · cited 3×
“Fzd10 was found ubiquitously upregulated in synovial sarcoma (SS), but scarcely detectable in normal tissues except the placenta.(101) A group of radioimmunoconjugate humanized antibody OTSA-101 was designed to target Fzd10, whose derivations include (211)At-OTSA-101, (111)In-OTSA-101, and (90)Y-OTSA-101.”
BackgroundInfluentialTraf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth
Shitashige, M., Satow, R., Jigami, T., Aoki, K., Honda, K., Shibata, T., Ono, M., Hirohashi, S., & Yamada, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0306 · Cited by 125 · cited 2×
“Tnik is an essential component for Wnt/β-catenin signaling to maintain physiological cell homeostasis.(250,251) Tnik can directly interact with β-catenin and Tcf to modulate Wnt/β-catenin signaling(250,251) (Fig.”
BackgroundTian, X.-H., Hou, W.-J., Fang, Y., Fan, J., Tong, H., Bai, S.-L., Chen, Q., Xu, H., & Li, Y. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-100 · Cited by 125 · cited 1×
“XAV939 and RNAi-Tnks1 inhibited the stemness and migration of cancer stem cells and accelerated cell apoptosis in neuroblastoma by attenuating the abnormal status of Wnt/β-catenin signaling.(332,333) XAV939 and IWR, the inhibitors of Tnks, repressed the growth of lung cancer and reduced tumorigenesis.”
BackgroundZhang, H., Zhang, X., Wu, X., Li, W., Su, P., Cheng, H., Xiang, L., Gao, P., & Zhou, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.039 · Cited by 125
Wang, F., He, L., Dai, W.-Q., Xu, Y.-P., Wu, D., Lin, C.-L., Wu, S.-M., Cheng, P., Zhang, Y., Shen, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050638 · Cited by 125
Self-citationSäfholm, A., Tuomela, J., Rosenkvist, J., Dejmek, J., Härkönen, P., & Andersson, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0711 · Cited by 124 · cited 1×
“In accordance, foxy-5 could prevent metastasis to some extent.(321,322) At present, WntResearch has supported five clinical trials registered on NIH and EUCTR, yet with no results posted (Table 2).”
BackgroundJohnson, V, Volikos, E., Halford, S. E., Eftekhar Sadat, E. T., Popat, S., Talbot, I., Truninger, K., Martin, J., Jass, J., Houlston, R., et al. (2005) · Gut · doi:10.1136/gut.2004.048132 · Cited by 123 · cited 14×
“The constitutive activation form of β-catenin, the exon 3 mutations, is believed to regulate the Signal Transduction and Targeted Therapy (2021) 6:307 genesis of hereditary non-polyposis CRC.208 In CRC, there are several mutations of β-catenin, leading to abnormally activated Wnt/β-catenin signaling.209 The mutations…”
BackgroundInfluentialFrizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations
Flanagan, D. J., Barker, N., Costanzo, N. S. D., Mason, E. A., Gurney, A., Meniel, V. S., Koushyar, S., Austin, C. R., Ernst, M., Pearson, H. B., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2095 · Cited by 122 · cited 6×
“Inhibitor targeting Fzd7 is effective for treating gastric cancer, no matter with Apc mutations or not.(84) Fzd7 may be an extraordinarily effective therapy for gastric and CRCs.”
BackgroundInfluentialRecent advances in understanding the cellular roles of GSK-3
Cormier, K. W., & Woodgett, J. R. (2017) · F1000Research · doi:10.12688/f1000research.10557.1 · Cited by 121 · cited 2×
“In Wnt/β-catenin signaling, generally, Gsk3 controls β-catenin degradation by comprising a degradation complex.(95,133,181) Axin, phosphorylated by Gsk3, binds to and phosphorylates β-catenin, resulting in β-catenin degradation by ubiquitin proteasome.”
Backgroundde la Roche, M., Rutherford, T. J., Gupta, D., Veprintsev, D. B., Saxty, B., Freund, S. M., & Bienz, M. (2012) · Nature Communications · doi:10.1038/ncomms1680 · Cited by 120
Research works printed but not linked: 4
- Schwarz-Romond T The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization Nat. Struct. Mol. Biol. 2007 14 484 492 10.1038/nsmb1247 17529994 · DOI · Paper page
- Hoey, T. (ed.) Development of FZD8-Fc (OMP-54 F28), aWnt signaling antagonist that inhibits tumor growth and reduces tumor initiating cell frequency. Presented at AACR Annual Meeting; 2013 April; Washington DC (2013).
- OncoMed Pharmaceuticals, Inc. A phase 1b dose escalation study of vantictumab (OMP-18R5) in combination with nab-paclitaxel and gemcitabine in patients with previously untreated stage IV pancreatic cancer. NCT02005315, 18R5-003R5. PMC7211194 31338636
- OncoMed Pharmaceuticals, Inc. A phase 1b dose escalation study of OMP-54F28 in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer. NCT02092363, 54F28-003. PMC7397408 31174889
Cited by
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Research progress of glutathione peroxidase family (GPX) in redoxidation
Pei, J., Pan, X., Wei, G., & Hua, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1147414 · Cited by 617
“In the Wnt pathway, the key step of the Wnt pathway is the binding of the Wnt protein to the Frizzled receptor, and the nuclear redox protein (NRX) blocks Disheveled (DVL) and plays a negative regulatory role in the Wnt pathway (Yu et al., 2021).”
Background(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
Self-citationWnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
“Consequently, extensive research has demonstrated the ability of rosmantuzumab to impede self-renewal and differentiation processes in acute myeloid leukemia cells within PDX models, while simultaneously preserving the normal physiological function of hematopoietic stem cells [347].”
BackgroundRole of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
“Specifically, FadA binds to E-cadherin on the membrane, leading to the phosphorylation and internalization of E-cadherin, which is accompanied by increased β-catenin release and translocation into the nucleus due to the degradation of the E-cadherin/ β-catenin complex, resulting in the aberrant activation of Wnt signa…”
Background
Metadata
- Authors
- Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Ye, Ling
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-08-30
- Volume
- 6
- Issue
- 1
- Pages
- 307-307
- ISSN
- 2059-3635 (ISSN-L)
- PMC
- PMC8403677
- OpenAlex
- W3198051187
- Cited by
- 734
- References
- 468
- Citations by year
- 2026: 106 · 2025: 234 · 2024: 200 · 2023: 139 · 2022: 53 · 2021: 2
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81825005)
- State Key Laboratory of Oral Disease
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt/β-catenin signaling, cancer, targeted therapy, aberrant signaling, malignant progression, prognosis, clinical translation, treatment resistance
- MeSH terms
- Humans, Neoplasm Proteins, Neoplasms, Wnt Proteins, beta Catenin, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.